Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited ... There is currently no vaccine to prevent or medicine to treat chikungunya virus infection.On 30 September 2016, Cadila ...

Sun Pharma and Zydus Pharmaceuticals are recalling significant quantities of their products in the US due to manufacturing ...

The companies in question, Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, are recalling seizure treatments, ...

Zydus Lifesciences Limited announced today it has received final approval from the US Food and Drug Administration (USFDA) to manufacture Methenamine Hippurate Tablets USP, 1 gram. The medication ...

The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Pimavanserin tablets in strength of 10 mg, Zydus Cadila said in a statement. Zydus Cadila ...

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

Zydus Lifesciences share price today, March 13: The share price of Zydus Lifesciences has cracked 2.6% in the last five days. (Image: Freepik) Nuvama Institutional Equities slashed the target ...

Zydus Lifesciences announced it is negotiating to acquire a majority stake in French medtech firm Amplitude Surgical for approximately Rs 2,500 crore. The acquisition aims to boost Zydus's global ...

Zydus Lifesciences is developing a combination vaccine targeting shigellosis and typhoid, with support from the Gates Foundation. The effort focuses on early-stage development and animal studies.

Zydus Lifesciences, one of India's leading drugmakers, is sprinting ahead of others to become a "beyond-the-pill" comprehensive healthcare solutions provider. Along with consumer health and ...

The proposed acquisition shall act as a platform to execute our global MedTech strategy and a natural extension for Zydus having a proven track record in life sciences and wellness segments ...

Zydus Lifesciences Limited on Tuesday announced that the company has entered into exclusive negotiations to acquire majority Amplitude Surgical. Purchase consideration amounts to €256.8mn for 85 ...